# Aldena Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aldena-therapeutics

- Industry: Biotechnology
- Headquarters: Boston, US
- Total disclosed funding: $30M
- Latest round: Series A (Mar 16, 2023)
- Investors on record: 1

## About

Based in Massachusetts, US, and founded in 2021, Aldena Therapeutics Inc. operates as a biotechnology research company that offers siRNA-based therapies for dermatological indications. The company was founded by John Harris, Mark Prausnitz and Andrew Tadros. In March 2023, Aldena Therapeutics Inc. raised USD 30 million in series A funding led by Medicxi Ventures. As of 2023, the company is led by its CEO Thibaud Portal.

The company offers siRNA-based treatments for patients suffering from dermatological diseases.

The company plans to use the March 2023 funding to accelerate its approach to Immuno dermatology.

## Funding rounds

- Series A, Mar 16, 2023, $30M — Medicxi

## Investors

- Medicxi (https://capitalatlas.ai/funds/medicxi) — Series A